Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GL ...
Related: Crazy-expensive weight loss drugs may soon see a major change In other news, The Biden Administration is set to ...
The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
Currently, fewer than one in five large employers are covering such prescriptions despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, according to a KFF analysis earlier ...
RBC Capital sees little reason for concern over CMS’ proposed GLP-1 coverage rule and its potential impact on MCOs. Should the rule go into effect in 2026 as proposed, plans would have adequate ...
We go into depth, covering what bariatric surgery is, who needs it, why insurance makes it so hard to get it, and, most ...